Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Glove Compression for Chemotherapy-Induced Neuropathy [NA]
A completed clinical trial evaluated glove compression therapy for chemotherapy-induced peripheral neuropathy in patients with gynecologic c…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy [Phase 2]
Phase 2 trial comparing intrathecal morphine with lidocaine infusion to epidural anesthesia with postoperative PCA for exploratory laparotom…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer [Phase 1, Phase 2]
An exploratory Phase 1/2 trial evaluating whether NK cell–assisted therapy can prevent chemotherapy-induced bone marrow suppression in ovari…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Alaunos Therapeutics reports long-term follow-up data from subjects treated with autologous T cells engineered with a Sleeping Beauty system…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Trial in Patients With Relapsed Ovarian Cancer [Phase 2]
Reports the completion of a Phase 2 trial in relapsed ovarian cancer conducted by the Nordic Society of Gynaecological Oncology - Clinical T…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody [Phase 2]
Phase 2 trial update of M701 bispecific antibody for malignant ascites in gastrointestinal or ovarian cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies [Phase 1]
This Phase 1 study of NP-G2-044, a metastasis inhibitor, in patients with advanced or metastatic treatment-refractory solid tumors has compl…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating systemic immune checkpoint blockade with intraperitoneal chemo-immunotherapy for recurrent ovarian …
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating MV-NIS infected mesenchymal stem cells for recurrent ovarian, primary peritoneal, or fallopian tube cancer. Res…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: A Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer (COHORT-C) [Phase 2]
A Phase 2 neoadjuvant trial (COHORT-C) comparing niraparib to platinum-taxane chemotherapy in homologous recombination–deficient advanced ov…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian Cancer [Phase 2]
Phase 2 study evaluating the efficacy and safety of novel treatment combinations in participants with ovarian cancer has completed, and resu…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the combination of focused ultrasound ablation with PD-1 antibody blockade in advanced solid tumors has been termin…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors [Phase 1]
A Phase 1 trial of INCB106385, alone or with immunotherapy, in advanced solid tumors has completed. The study includes multiple indications …
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations [Phase 2]
A Phase 2 trial evaluating Copanlisib in combination with Fulvestrant in ER+/PR+ cancers with PI3K/PTEN alterations was terminated, with tri…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy [Phase 3]
A Phase 3 trial evaluating olaparib as maintenance monotherapy in relapsed ovarian cancer after a complete or partial response to platinum c…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients [Phase 3]
Phase 3 trial of maintenance Fluzoparib versus placebo in relapsed ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer [Phase 2]
Phase 2 trial update describing a study on personalized timing of interval debulking surgery for advanced ovarian cancer; recruitment is ong…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer
Completed clinical trial from Institut Bergonié evaluating elderly patients' expectations and priorities for a first-line cancer treatment a…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Biomarker Screening Protocol for Participants With Solid Tumors
A clinical trial update describes a biomarker screening protocol for participants with solid tumors, and the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules [Phase 1]
This Phase 1 trial evaluates increasing doses and different treatment schedules of the AKT inhibitor AZD5363 (ipatasertib) in patients with …
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer [Phase 1]
Phase 1 dose-escalation study evaluating lapatinib in combination with paclitaxel for ovarian cancer; safety and tolerability results have b…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor [Phase 1]
Phase 1 trial evaluating carbon nanoparticle-loaded iron (CNSI-Fe(II)) in patients with advanced solid tumors has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 4]
A Phase 4 interventional trial evaluating Avastin (bevacizumab) in advanced or metastatic ovarian, fallopian tube, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating intensive locoregional chemoimmunotherapy with intranodal dendritic cell vaccines for recurrent ov…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: NeoVax With Nivolumab in Patients With Ovarian Cancer [Phase 1]
Phase 1 trial evaluating NeoVax in combination with nivolumab for ovarian cancer is currently active/not recruiting.